Bhargava, P <br/><br/>
A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2001 
 - 3912-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--pharmacokinetics<br/>Anticarcinogenic Agents--pharmacokinetics<br/>Cholestanols--pharmacokinetics<br/>Dose-Response Relationship, Drug<br/>Fatigue--chemically induced<br/>Female<br/>Humans<br/>Liver--drug effects<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Neoplasms--drug therapy